Завод ДИОД DIOD

Завод ДИОД Financial Ratios 2007-2025 | DIOD

Annual Financial Ratios Завод ДИОД

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Price Earnings Ratio, P/E	171.2	17.39	8.02	18.37	6.76	34.25	-17.77	-2.12	-3.2	5.41	-2.3	46.55	11.82	18.46	7.83	0.0	0.0
Price Sales Ratio, P/S	2.63	1.25	1.21	1.32	0.66	0.49	0.56	0.34	0.4	0.24	0.32	0.55	0.97	1.94	1.88	0.0	0.0
Price To Book Ratio, P/B	1.27	0.58	0.59	0.57	0.36	0.32	0.34	0.21	0.25	0.18	0.22	0.35	0.82	1.65	1.71	0.0	0.0
Price Earnings To Growth Ratio, PEG	-2.16	-0.31	0.05	-0.4	0.01	-0.24	0.22	-0.12	0.01	-0.04	0.0	-0.52	-0.55	-0.33	-0.08	-0.0	-
Operating Cash Flow Per Share	0.03	0.0	0.0	0.0	1.85	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	15370.93
Free Cash Flow Per Share	-0.35	0.0	-0.12	-0.01	1.83	-0.17	0.0	-0.0	1.13	0.57	-0.36	-0.02	-0.07	-0.19	-0.24	-3745.79	15117.49
Cash Per Share	0.37	2.29	1.93	1.31	0.33	1.12	0.92	0.99	1.57	0.02	0.15	0.19	0.19	0.42	0.42	3126.89	2527.87
Payout Ratio	8.63	0.0	0.6	1.04	0.6	3.03	-0.0	-0.0	-0.09	0.42	-0.07	1.67	0.42	0.06	0.07	0.04	-
Dividend Yield	0.05	0.0	0.07	0.06	0.09	0.09	0.0	0.0	0.03	0.08	0.03	0.04	0.04	0.0	0.01	45.31	-
Current Ratio	6.72	7.56	9.22	8.75	5.75	5.02	4.95	5.72	3.11	1.82	2.44	3.76	2.94	2.9	1.73	2.44	2.26
Quick Ratio	4.22	4.65	5.61	4.92	3.14	2.67	2.12	2.26	1.26	0.8	1.45	2.4	1.97	1.74	0.84	1.18	1.42
Cash Ratio	0.26	0.87	0.87	0.47	0.03	0.17	0.04	0.06	0.38	0.0	0.02	0.04	0.03	0.08	0.05	0.06	0.06
Days Of Sales Outstanding, DSO	204.37	-	213.41	251.13	239.58	172.78	114.3	110.19	106.68	104.26	213.96	251.45	182.99	192.83	131.91	108.46	123.35
Days Of Inventory Outstanding, DIO	466.79	540.78	545.11	767.96	505.37	477.25	467.31	459.56	800.12	470.68	611.43	517.97	279.75	276.4	321.55	313.16	180.94
Days Of Payables Outstanding, DPO	21.45	21.07	46.49	144.57	141.34	93.18	99.01	39.08	121.37	70.69	55.61	0.34	49.18	17.54	22.52	26.11	11.36
Operating Cycle	671.16	540.78	758.51	1019.1	744.95	650.03	581.61	569.75	906.8	574.94	825.38	769.42	462.73	469.22	453.47	421.62	304.3
Cash Conversion Cycle	649.71	519.71	712.02	874.53	603.61	556.85	482.6	530.67	785.43	504.26	769.77	769.08	413.55	451.68	430.95	395.51	292.93
Gross Profit Margin	0.54	0.57	0.59	0.63	0.54	0.58	0.5	0.45	0.67	0.55	0.65	0.6	0.54	0.51	0.53	0.61	0.58
Operating Profit Margin	0.0	0.08	0.18	0.14	0.15	0.07	-0.06	0.06	0.1	0.14	0.16	0.14	0.19	0.2	0.34	0.26	0.21
Pretax Profit Margin	0.02	0.11	0.19	0.11	0.12	0.06	-0.03	-0.15	-0.11	0.06	-0.12	0.02	0.1	0.11	0.26	0.24	0.21
Net Profit Margin	0.02	0.07	0.15	0.07	0.1	0.01	-0.03	-0.16	-0.12	0.04	-0.14	0.01	0.08	0.11	0.24	0.17	0.14
Effective Tax Rate	0.37	0.29	0.23	0.39	0.19	0.78	0.39	-0.05	-0.13	0.28	-0.15	0.68	0.25	0.21	0.11	0.26	0.3
Return On Assets, ROA	0.01	0.03	0.06	0.03	0.04	0.01	-0.02	-0.08	-0.06	0.02	-0.06	0.0	0.04	0.05	0.12	0.13	0.15
Return On Equity, ROE	0.01	0.03	0.07	0.03	0.05	0.01	-0.02	-0.1	-0.08	0.03	-0.1	0.01	0.07	0.09	0.22	0.22	0.21
Return On Capital Employed, ROCE	0.0	0.03	0.08	0.06	0.08	0.05	-0.03	0.03	0.06	0.1	0.09	0.06	0.1	0.11	0.22	0.24	0.28
Net Income Per Ebt	0.63	0.67	0.79	0.65	0.8	0.23	0.98	1.05	1.13	0.71	1.15	0.54	0.85	0.99	0.91	0.74	0.68
Ebt Per Ebit	7.37	1.33	1.07	0.78	0.81	0.83	0.58	-2.71	-1.15	0.44	-0.75	0.15	0.52	0.55	0.78	0.89	1.01
Ebit Per Revenue	0.0	0.08	0.18	0.14	0.15	0.07	-0.06	0.06	0.1	0.14	0.16	0.14	0.19	0.2	0.34	0.26	0.21
Debt Ratio	-	-	0.03	0.0	0.01	0.05	0.03	0.01	0.01	0.18	0.3	0.3	0.21	0.18	0.17	0.22	0.12
Debt Equity Ratio	-	-	0.04	0.0	0.01	0.06	0.04	0.01	0.01	0.27	0.51	0.52	0.4	0.34	0.31	0.38	0.17
Long Term Debt To Capitalization	-	-	-	-	0.03	0.01	0.01	0.01	0.0	0.0	0.17	0.28	0.2	0.17	0.04	0.18	-
Total Debt To Capitalization	-	-	0.04	0.0	0.01	0.06	0.04	0.01	0.01	0.21	0.34	0.34	0.29	0.25	0.24	0.27	0.14
Interest Coverage	-	1222.43	5633.42	127.13	28.15	-	-1.98	1.33	0.82	1.95	1.83	1.67	3.25	3.23	4.52	10.37	164.81
Cash Flow To Debt Ratio	-	-	0.0	0.07	21.21	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	0.77
Company Equity Multiplier	1.19	1.17	1.15	1.16	1.2	1.21	1.21	1.19	1.31	1.5	1.7	1.72	1.96	1.84	1.81	1.72	1.45
Receivables Turnover	1.79	-	1.71	1.45	1.52	2.11	3.19	3.31	3.42	3.5	1.71	1.45	1.99	1.89	2.77	3.37	2.96
Payables Turnover	17.01	17.32	7.85	2.52	2.58	3.92	3.69	9.34	3.01	5.16	6.56	1063.66	7.42	20.81	16.21	13.98	32.12
Inventory Turn Over	0.78	0.67	0.67	0.48	0.72	0.76	0.78	0.79	0.46	0.78	0.6	0.7	1.3	1.32	1.14	1.17	2.02
Fixed Asset Turnover	2.2	2.16	2.23	1.93	2.39	3.12	3.12	3.28	3.42	4.38	3.74	3.62	3.17	3.42	3.52	4.31	4.23
Asset Turnover	0.41	0.4	0.42	0.37	0.45	0.54	0.51	0.53	0.47	0.51	0.41	0.37	0.43	0.46	0.5	0.74	1.03
Operating Cash Flow Sales Ratio	0.01	0.0	0.0	0.0	0.26	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	0.09
Free Cash Flow Operating Cash Flow Ratio	-10.39	0.97	-103.26	-10.64	0.99	-295.91	0.62	1.02	-	-	-	-	-	-	-	-	0.98
Cash Flow Coverage Ratios	-	-	0.0	0.07	21.21	0.0	0.0	-0.0	-	-	-	-	-	-	-	-	0.77
Short Term Coverage Ratios	-	-	0.02	0.07	21.21	0.0	0.0	-0.01	-	-	-	-	-	-	-	-	0.77
Capital Expenditure Coverage Ratio	0.09	36.09	0.01	0.09	83.3	0.0	2.61	-41.64	-	-	-	-	-	-	-	-	60.65
Dividend Paid And Capex Coverage Ratio	0.03	1.38	0.0	0.0	4.18	0.0	1.19	-41.22	-	-	-	-	-	-	-	-	60.65
Dividend Payout Ratio	8.63	0.0	0.6	1.04	0.6	3.03	-0.0	-0.0	-0.09	0.42	-0.07	1.67	0.42	0.06	0.07	0.04	-
Price To Free Cash Flows Ratio, P/FCF	-45.1	7196.53	-67.86	-719.95	2.58	-24.09	9568.71	-3567.51	3.71	5.91	-10.84	-387.96	-232.77	-171.45	-132.63	-0.01	0.0
Price To Operating Cash Flows Ratio, P/OCF	468.51	6997.11	7007.48	7657.5	2.55	7128.65	5897.15	-3653.19	-	-	-	-	-	-	-	-	0.0
Price Cash Flow Ratio, P/CF	468.51	6997.11	7007.48	7657.5	2.55	7128.65	5897.15	-3653.19	-	-	-	-	-	-	-	-	0.0
Enterprise Value Multiple, EV	62.85	9.12	5.22	8.22	4.02	4.62	14.36	-4.61	20.81	4.11	186.13	10.26	8.9	13.84	6.0	1.08	0.44
Price Fair Value, P/FV	1.27	0.58	0.59	0.57	0.36	0.32	0.34	0.21	0.25	0.18	0.22	0.35	0.82	1.65	1.71	0.0	0.0

All numbers in RUB currency

Quarterly Financial Ratios Завод ДИОД

	2023-Q2	2022-Q4	2022-Q2	2021-Q4	2021-Q2	2020-Q4	2020-Q2	2019-Q4	2019-Q2	2018-Q4	2018-Q2	2017-Q4	2017-Q2	2016-Q4	2016-Q2	2015-Q4	2015-Q2	2014-Q4	2014-Q2	2013-Q4	2013-Q2	2011-Q4	2011-Q2	2010-Q4	2010-Q2	2009-Q4	2009-Q2	2008-Q4	2008-Q2
Price Earnings Ratio, P/E	69.1	6.56 K	12	6.38	3.72	5.6	15.9	14.3	1.99	-10.2	5.66	-1.93	2.64	-2.18	-0.813	-1.21	-2.36	2.7	3.38	8.69	-1.13	5.91	8.06	9.23	8.68	3.92	3.92	0.001	0.0
Price Sales Ratio, P/S	4.24	2.7 K	2.47	2.48	3	2.19	2.35	1.35	1.35	0.987	1.18	1.26	0.795	0.723	0.733	0.7	0.93	0.482	0.603	0.565	1.51	1.95	2.66	3.88	3.64	3.76	3.76	0.0	0.0
Price To Book Ratio, P/B	1.01	0.582	0.632	0.588	0.767	0.541	0.419	0.357	0.379	0.322	0.346	0.345	0.256	0.211	0.239	0.247	0.236	0.184	0.236	0.222	0.229	0.816	1.12	1.65	1.6	1.71	1.9	-	0.0
Price Earnings To Growth Ratio, PEG	0.003	-65.7	-0.265	-0.117	0.033	0.022	1.75	-0.165	-0.003	0.07	-0.043	0.007	-0.013	0.032	-0.023	-0.013	0.01	-	0.019	-0.077	0.001	-	-0.377	-	-0.154	-	-0.039	-	-0.0
Operating Cash Flow Per Share	0.017	0.0	0.72	0.405	0.762	0.627	0.342	0.491	1.39	0.56	-	0.001	-0.0	-0.0	-0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow Per Share	-0.175	0.0	0.711	0.344	0.704	0.616	0.342	0.541	1.31	0.528	-0.087	0.001	-0.0	-0.0	-0.0	0.566	0.566	0.286	0.286	-0.182	-0.182	-0.035	-0.035	-0.096	-0.096	-0.121	-0.121	-936	-1.87 K
Cash Per Share	2.52	2.3	2.66	1.93	2.12	1.37	0.699	0.334	1.4	1.11	1.04	0.921	1.03	0.991	1.38	1.57	0.046	0.02	0.161	0.154	0.228	0.189	0.302	0.415	0.418	0.42	0.367	-	2.83 K
Payout Ratio	8.63	2.62	0.0	1.88	0.005	1.33	-	5.13	0.17	-3.56	0.819	-0.001	-	-0.0	-	-0.068	-0.133	0.425	0.425	0.538	-0.067	0.422	0.422	0.063	0.063	0.065	0.065	0.029	0.044
Dividend Yield	0.031	0.0	0.0	0.074	0.0	0.059	-	0.089	0.021	0.088	0.036	0.0	-	0.0	-	0.014	0.014	0.039	0.031	0.015	0.015	0.018	0.013	0.002	0.002	0.004	0.004	11.3	22.7
Current Ratio	5	7.56	5.58	9.22	5.84	8.75	6.53	5.75	5.24	5.02	4.52	4.95	4.2	5.72	2.55	3.11	1.88	1.82	1.88	2.44	3.06	2.94	2.92	2.9	2.21	1.73	2.01	-	2.35
Quick Ratio	3.23	4.65	3.41	5.61	3.51	4.92	3.69	3.14	2.63	2.67	2.1	2.12	2.02	2.26	1.31	1.26	0.714	0.796	1.08	1.45	1.83	1.97	1.87	1.74	1.21	0.838	0.972	-	1.29
Cash Ratio	0.643	0.874	0.839	0.872	0.643	0.474	0.231	0.025	0.305	0.166	0.088	0.041	0.055	0.061	0.087	0.385	0.007	0.002	0.019	0.021	0.037	0.031	0.052	0.077	0.063	0.054	0.057	-	0.06
Days Of Sales Outstanding, DSO	-	126 K	89	108	105	117	139	121	74.6	85.7	62.6	62.8	71.8	58.3	101	46.2	65	-	-	-	-	90.2	92.6	95.1	80.3	65.1	62.2	-	55.3
Days Of Inventory Outstanding, DIO	240	274 K	255	239	311	318	476	324	222	226	291	245	230	241	231	272	487	232	187	259	743	138	141	136	145	159	151	-	122
Days Of Payables Outstanding, DPO	37.9	10.7 K	12.3	20.4	10.9	59.9	74.2	90.6	13.5	44.1	15.2	52	30	20.5	115	41.3	84.9	34.9	26	23.5	97.9	24.3	16.7	8.65	9.68	11.1	11.5	-	9.25
Operating Cycle	240	401 K	344	347	416	436	615	445	296	312	354	308	302	300	331	319	552	232	187	259	743	228	234	231	225	224	213	-	177
Cash Conversion Cycle	202	390 K	332	326	405	376	540	354	283	267	339	256	272	279	217	277	467	197	161	235	645	204	217	223	215	213	202	-	168
Gross Profit Margin	0.536	0.547	0.566	0.53	0.632	0.618	0.642	0.642	0.437	0.555	0.596	0.478	0.52	0.448	0.455	0.584	0.668	0.546	0.546	0.635	0.665	0.541	0.541	0.514	0.514	0.534	0.534	0.583	0.611
Operating Profit Margin	0.003	0.108	0.061	0.056	0.242	0.131	0.04	0.073	0.083	0.015	0.13	-0.19	0.053	-0.026	0.127	0.165	0.003	0.143	0.143	0.145	0.182	0.188	0.188	0.195	0.195	0.336	0.336	0.205	0.264
Pretax Profit Margin	0.024	0.126	0.09	0.119	0.258	0.141	0.069	0.089	0.155	0.045	0.075	-0.176	0.084	-0.039	-0.25	-0.059	-0.177	0.063	0.063	0.034	-0.317	0.097	0.097	0.107	0.107	0.263	0.263	0.206	0.236
Net Profit Margin	0.015	0.103	0.052	0.097	0.202	0.098	0.037	0.023	0.169	-0.024	0.052	-0.163	0.075	-0.083	-0.225	-0.144	-0.098	0.045	0.045	0.016	-0.335	0.082	0.082	0.105	0.105	0.24	0.24	0.141	0.175
Effective Tax Rate	0.372	0.227	0.375	0.252	0.217	0.369	0.449	0.719	-0.097	1.42	0.401	0.219	0.096	-1.19	0.207	-1.43	0.903	0.281	0.281	0.489	-0.062	0.252	0.252	0.215	0.215	0.112	0.112	0.301	0.259
Return On Assets, ROA	0.003	0.0	0.011	0.02	0.043	0.021	0.006	0.005	0.039	-0.007	0.012	-0.037	0.019	-0.02	-0.051	-0.039	-0.017	0.011	0.011	0.004	-0.03	0.018	0.018	0.024	0.025	0.06	0.069	-	0.077
Return On Equity, ROE	0.004	0.0	0.013	0.023	0.051	0.024	0.007	0.006	0.048	-0.008	0.015	-0.045	0.024	-0.024	-0.073	-0.051	-0.025	0.017	0.017	0.006	-0.051	0.035	0.035	0.045	0.046	0.109	0.121	-	0.123
Return On Capital Employed, ROCE	0.001	0.0	0.015	0.012	0.058	0.03	0.007	0.018	0.022	0.005	0.035	-0.049	0.016	-0.007	0.039	0.054	0.001	0.051	0.049	0.045	0.02	0.048	0.049	0.053	0.058	0.11	0.122	-	0.149
Net Income Per Ebt	0.628	0.815	0.574	0.817	0.781	0.695	0.532	0.264	1.09	-0.538	0.693	0.929	0.896	2.13	0.901	2.44	0.555	0.705	0.705	0.484	1.06	0.851	0.851	0.985	0.985	0.912	0.912	0.684	0.741
Ebt Per Ebit	7.37	1.17	1.47	2.13	1.07	1.07	1.71	1.23	1.88	2.94	0.581	0.923	1.6	1.5	-1.97	-0.359	-56.3	0.442	0.442	0.232	-1.75	0.516	0.516	0.545	0.545	0.783	0.783	1.01	0.894
Ebit Per Revenue	0.003	0.108	0.061	0.056	0.242	0.131	0.04	0.073	0.083	0.015	0.13	-0.19	0.053	-0.026	0.127	0.165	0.003	0.143	0.143	0.145	0.182	0.188	0.188	0.195	0.195	0.336	0.336	0.205	0.264
Debt Ratio	-	-	0.0	0.033	-	0.001	0.029	0.006	0.026	0.05	0.041	0.034	0.023	0.01	0.008	0.011	0.17	0.179	0.238	0.299	0.323	0.205	0.195	0.183	0.177	0.171	0.192	-	0.178
Debt Equity Ratio	-	-	0.0	0.038	-	0.001	0.035	0.007	0.032	0.061	0.05	0.041	0.028	0.012	0.012	0.015	0.248	0.27	0.382	0.507	0.551	0.402	0.37	0.337	0.324	0.31	0.34	-	0.284
Long Term Debt To Capitalization	-	-	-	0.033	-	-	0.027	0.027	0.006	0.006	0.006	0.005	0.005	0.005	0.005	0.005	0.005	0.004	0.06	0.173	0.231	0.199	0.186	0.173	0.115	0.042	0.111	-	0.112
Total Debt To Capitalization	-	-	0.0	0.037	-	0.001	0.034	0.007	0.031	0.057	0.048	0.039	0.028	0.012	0.012	0.014	0.199	0.213	0.276	0.336	0.355	0.287	0.27	0.252	0.245	0.237	0.254	-	0.221
Interest Coverage	-	-	-	28.8	176	-	-	0.055	0.012	-	-	-3	-	-	-	-	-	1.95	1.95	-	-	3.25	3.25	3.23	3.23	4.52	4.52	165	10.4
Cash Flow To Debt Ratio	-	-	1.58 K	0.787	-	47.2	0.723	5.59	3.3	0.725	-	0.002	-0.001	-0.002	-0.002	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Company Equity Multiplier	1.25	1.17	1.22	1.15	1.21	1.16	1.18	1.2	1.21	1.21	1.23	1.21	1.24	1.19	1.43	1.31	1.46	1.5	1.6	1.7	1.71	1.96	1.9	1.84	1.83	1.81	1.77	-	1.6
Receivables Turnover	-	0.001	1.01	0.834	0.855	0.767	0.648	0.745	1.21	1.05	1.44	1.43	1.25	1.54	0.895	1.95	1.38	-	-	-	-	0.997	0.972	0.946	1.12	1.38	1.45	-	1.63
Payables Turnover	2.37	0.008	7.33	4.42	8.25	1.5	1.21	0.994	6.66	2.04	5.9	1.73	3	4.39	0.784	2.18	1.06	2.58	3.46	3.82	0.919	3.71	5.39	10.4	9.3	8.11	7.81	-	9.73
Inventory Turn Over	0.376	0.0	0.353	0.377	0.29	0.283	0.189	0.278	0.406	0.398	0.309	0.367	0.392	0.373	0.39	0.33	0.185	0.388	0.481	0.348	0.121	0.652	0.638	0.66	0.622	0.568	0.596	-	0.737
Fixed Asset Turnover	1.07	0.001	1.15	1.09	1.15	1.11	0.802	1.17	1.3	1.55	1.5	1.4	1.71	1.53	1.71	1.95	1.45	2.19	2.15	2.1	0.804	1.59	1.65	1.71	1.73	1.76	1.85	-	2.2
Asset Turnover	0.191	0.0	0.21	0.207	0.212	0.214	0.151	0.222	0.233	0.27	0.238	0.227	0.259	0.245	0.228	0.269	0.174	0.254	0.245	0.232	0.089	0.214	0.222	0.231	0.24	0.251	0.286	-	0.441
Operating Cash Flow Sales Ratio	0.006	0.149	0.218	0.126	0.226	0.197	0.14	0.14	0.373	0.135	-	0.0	-0.0	-0.0	-0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow Operating Cash Flow Ratio	-10.4	0.95	0.987	0.851	0.924	0.982	1	1.1	0.948	0.942	-	0.757	1.27	1	1.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Coverage Ratios	-	-	1.58 K	0.787	-	47.2	0.723	5.59	3.3	0.725	-	0.002	-0.001	-0.002	-0.002	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Coverage Ratios	-	-	-	8.68	-	47.2	3.68	5.59	4.12	0.809	-	0.002	-0.001	-0.004	-0.004	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital Expenditure Coverage Ratio	0.088	0.02	77.5	6.69	13.2	56.5	-	9.97	19.1	17.1	-	4.11	-3.71	-	-20.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend Paid And Capex Coverage Ratio	0.029	0.019	77	0.625	12.4	1.47	-	1.04	7.73	1.43	-	1.66	-3.71	-2.06 K	-20.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	8.63	2.62	0.0	1.88	0.005	1.33	-	5.13	0.17	-3.56	0.819	-0.001	-	-0.0	-	-0.068	-0.133	0.425	0.425	0.538	-0.067	0.422	0.422	0.063	0.063	0.065	0.065	0.029	0.044
Price To Free Cash Flows Ratio, P/FCF	-72.8	19.1 K	11.5	23.1	14.4	11.3	16.7	8.75	3.81	7.79	-58.8	6.12 K	-13.2 K	-7.24 K	-8.18 K	7.42	7.45	11.8	14.8	-21.7	-22.7	-466	-635	-343	-322	-265	-265	-0.034	-0.017
Price To Operating Cash Flows Ratio, P/OCF	757	18.2 K	11.3	19.7	13.3	11.1	16.7	9.62	3.61	7.34	-	4.63 K	-16.8 K	-7.24 K	-8.58 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Price Cash Flow Ratio, P/CF	757	18.2 K	11.3	19.7	13.3	11.1	16.7	9.62	3.61	7.34	-	4.63 K	-16.8 K	-7.24 K	-8.58 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Enterprise Value Multiple, EV	92.9	17.2 K	20.9	29.5	9.19	9.17	27.9	17.3	9.91	23.1	7.05	-21.1	6.46	22.8	5.4	-3.67	96.3	8.22	10.8	10.8	23.6	17.8	21.6	27.7	25.9	12	12	-	1.43
Price Fair Value, P/FV	1.01	0.582	0.632	0.588	0.767	0.541	0.419	0.357	0.379	0.322	0.346	0.345	0.256	0.211	0.239	0.247	0.236	0.184	0.236	0.222	0.229	0.816	1.12	1.65	1.6	1.71	1.9	-	0.0

All numbers in RUB currency

Multiples are an important financial analysis tool for the company Завод ДИОД, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios

Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Biotechnology industry

Issuer	Price	% 24h	Market Cap	Country
AbbVie ABBV	$ 223.01	-0.99 %	$ 395 B	USA
ARCA biopharma ABIO	-	1052.0 %	$ 415 M	USA
Arbutus Biopharma Corporation ABUS	$ 4.68	1.85 %	$ 777 M	Canada
Aclaris Therapeutics ACRS	$ 3.38	3.21 %	$ 261 M	USA
Acasti Pharma ACST	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	-	-15.15 %	$ 60.3 M	Britain
Aeglea BioTherapeutics AGLE	-	-	$ 1.01 B	USA
Ascendis Pharma A/S ASND	$ 212.3	5.5 %	$ 5 B	Danmark
Alexion Pharmaceuticals, Inc. ALXN	-	-	$ 40.3 B	USA
BioVie BIVI	$ 1.54	-2.53 %	$ 2.28 M	USA
Albireo Pharma ALBO	-	-0.23 %	$ 916 M	USA
Aptorum Group Limited APM	$ 1.33	-1.48 %	$ 7.25 M	China
Alpine Immune Sciences ALPN	-	-	$ 2.17 B	USA
Alterity Therapeutics Limited ATHE	$ 3.4	1.49 %	$ 8.18 B	Australia
EyeGate Pharmaceuticals, Inc. EYEG	-	-1.52 %	$ 24.7 M	USA
AstraZeneca PLC AZN	$ 90.34	-1.28 %	$ 96.9 B	Britain
Amphastar Pharmaceuticals AMPH	$ 25.76	0.19 %	$ 1.25 B	USA
Anika Therapeutics ANIK	$ 9.53	-1.19 %	$ 140 M	USA
Aytu BioScience AYTU	$ 2.33	2.3 %	$ 14.6 M	USA
Arena Pharmaceuticals ARNA	-	-6.81 %	$ 3.04 B	USA
Avenue Therapeutics ATXI	-	-52.27 %	$ 4.45 M	USA
Институт стволовых клеток человека ISKJ	-	-	-	Russia
Axon Enterprise AXON	$ 586.28	3.15 %	$ 44.4 B	USA
Biogen BIIB	$ 173.03	-2.55 %	$ 25.2 B	USA
Can-Fite BioPharma Ltd. CANF	$ 0.29	-5.01 %	$ 631 M	Israel
Brickell Biotech BBI	-	-5.38 %	$ 6.06 M	USA
Benitec Biopharma BNTC	$ 12.91	0.78 %	$ 531 M	USA
BioNTech SE BNTX	$ 95.9	0.17 %	$ 27.2 B	Germany
Biohaven Pharmaceutical Holding Company Ltd. BHVN	$ 11.55	8.86 %	$ 747 M	USA
Enochian Biosciences ENOB	-	-	$ 40.5 M	USA
Catalyst Biosciences CBIO	$ 15.32	5.73 %	$ 1.01 B	USA
Acer Therapeutics ACER	-	2.71 %	$ 14 M	USA
BeiGene, Ltd. BGNE	-	0.49 %	$ 251 B	Cayman-islands
Cerus Corporation CERS	$ 2.14	13.23 %	$ 395 M	USA
Acorda Therapeutics ACOR	-	-24.86 %	$ 820 K	USA
Applied Molecular Transport AMTI	-	-	$ 10.1 M	USA
Burford Capital Limited BUR	$ 9.15	-0.44 %	$ 1.47 B	Britain
Berkeley Lights BLI	-	-7.31 %	$ 87 M	USA
bluebird bio BLUE	-	-	$ 546 M	USA
Cellectar Biosciences CLRB	$ 3.81	-5.35 %	$ 46.6 M	USA
Bristol-Myers Squibb Company BMY	$ 51.05	-0.32 %	$ 103 B	USA
Abeona Therapeutics ABEO	$ 5.5	0.46 %	$ 118 M	USA
ADiTx Therapeutics ADTX	$ 2.36	-7.29 %	$ 31.1 K	USA
BioXcel Therapeutics BTAI	$ 2.1	-4.34 %	$ 5.32 M	USA
Coherus BioSciences CHRS	$ 1.42	6.77 %	$ 134 M	USA
BioLineRx Ltd. BLRX	$ 3.22	-2.72 %	$ 908 M	Israel
Celldex Therapeutics CLDX	$ 28.33	0.5 %	$ 1.82 M	USA
Advaxis ADXS	-	-9.65 %	$ 45.9 M	USA
Baudax Bio BXRX	-	0.59 %	$ 63 K	USA

Завод ДИОД Financial Ratios 2007-2025 | DIOD

Annual Financial Ratios Завод ДИОД

Price Earnings Ratio, P/E

Price Sales Ratio, P/S

Price To Book Ratio, P/B

Price Earnings To Growth Ratio, PEG

Operating Cash Flow Per Share

Free Cash Flow Per Share

Cash Per Share

Payout Ratio

Dividend Yield

Current Ratio

Quick Ratio

Cash Ratio

Days Of Sales Outstanding, DSO

Days Of Inventory Outstanding, DIO

Days Of Payables Outstanding, DPO

Operating Cycle

Cash Conversion Cycle

Gross Profit Margin

Operating Profit Margin

Pretax Profit Margin

Net Profit Margin

Effective Tax Rate

Return On Assets, ROA

Return On Equity, ROE

Return On Capital Employed, ROCE

Net Income Per Ebt

Ebt Per Ebit

Ebit Per Revenue

Debt Ratio

Debt Equity Ratio

Long Term Debt To Capitalization

Total Debt To Capitalization

Interest Coverage

Cash Flow To Debt Ratio

Company Equity Multiplier

Receivables Turnover

Payables Turnover

Inventory Turn Over

Fixed Asset Turnover

Asset Turnover

Operating Cash Flow Sales Ratio

Free Cash Flow Operating Cash Flow Ratio

Cash Flow Coverage Ratios

Short Term Coverage Ratios

Capital Expenditure Coverage Ratio

Dividend Paid And Capex Coverage Ratio

Dividend Payout Ratio

Price To Free Cash Flows Ratio, P/FCF

Price To Operating Cash Flows Ratio, P/OCF

Price Cash Flow Ratio, P/CF

Enterprise Value Multiple, EV

Price Fair Value, P/FV